Home
Bellevue Group reported a 1.5% stake in Celldex Therapeutics CLDX · 1,200,000 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 1.5%
- Last report
- 5.4% · filed 25/11/14
- Shares held
- 1,200,000 sh
- Class
- Common Stock
- Holder
- Bellevue Group
- Event date
- 26/03/31
- Filed
- 26/05/15
1.5% stake · below 5%
- Stake
- 1.5%
- Last report
- 5.4%
- Since last report
- −3.9pp
Celldex Therapeutics trades, last 26 weeks
What else happened in Celldex Therapeutics around then
Filed or reported within 30 days of the trade day · 03/01~04/30Bellevue Group's other 5% stake reports
- Bellevue Group
5% stakeJade Biosciences
5% stakeJade Biosciences
JBIO
5% stake
3,057,996 sh
5% stake
Filed 08/14
- Bellevue Group
5% stakeViridian Therapeutics, Inc.\DE
5% stakeViridian Therapeutics, Inc.\DE
VRDN
6.6% stake
6,726,144 sh
6.6% stake
Filed 05/15
- Bellevue Group
5% stakeJade Biosciences
5% stakeJade Biosciences
JBIO
6.8% stake
3,341,103 sh
6.8% stake
Filed 02/17
- Bellevue Group
5% stakeMacrogenics
5% stakeMacrogenics
MGNX
0% stake
0 sh
0% stake
Filed 01/06
- Bellevue Group
5% stakeAgios Pharmaceuticals
5% stakeAgios Pharmaceuticals
AGIO
0% stake
0 sh
0% stake
Filed 25/12/05
